🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Jacobs Engineering selected by Aerie Pharmaceuticals as its Engineering Contractor

Published 09/19/2017, 08:01 AM
© Reuters.  Jacobs Engineering selected by Aerie Pharmaceuticals as its Engineering Contractor
J
-
AERI
-
  • Jacobs Engineering Group (NYSE:JEC) has been selected by Aerie Pharmaceuticals (NASDAQ:AERI) to provide engineering, procurement and construction management services for Aerie’s first pharmaceutical manufacturing facility, located in the Industrial Development Authority advanced technology building in Athlone, Republic of Ireland.
  • “Leveraging our extensive experience in EPCM for fill-finish facilities, we’ll work alongside Aerie to support their important goal of developing first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye,” said Jacobs Life Sciences, Consumer Goods and Manufacturing Senior Vice President and General Manager Ken Gilmartin.
  • “Key to Aerie’s selection of Jacobs to support the design and construction of our first manufacturing plant was their proven capability and track record of delivering sterile manufacturing facilities,” said Barry Ivin, Site Director, Aerie Athlone.
  • Press Release
  • Now read: Will The Federal Reserve Send The Market Higher?


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.